The Plekha3 Monoclonal Antibody (PAC011295) is a valuable tool for researchers studying Plekha3, a protein that plays a key role in cell signaling and adhesion. This antibody, produced using hybridoma technology, specifically targets Plekha3 in human samples and is validated for use in various applications such as immunofluorescence and immunohistochemistry.Plekha3 is a critical component of cell junctions and is involved in regulating cell-to-cell adhesion and communication. Its importance in maintaining tissue integrity and function makes it a relevant target in the study of developmental biology, cancer metastasis, and tissue repair processes.
Understanding the function of Plekha3 can provide insights into mechanisms underlying disease progression and potential therapeutic interventions. Overall, the Plekha3 Monoclonal Antibody (PAC011295) is a reliable tool for researchers investigating the role of Plekha3 in various cellular processes and disease states, ultimately contributing to advancements in biomedical research and potentially leading to the development of novel therapeutic strategies.
